Insider Trades
News
globenewswire.comSerina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updatesglobenewswire.comMay 14
globenewswire.comSeres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Diseaseglobenewswire.comMay 4
globenewswire.comSeres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026globenewswire.comApr 20
globenewswire.comSeres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026globenewswire.comApr 20
globenewswire.comSerina Therapeutics to Present at the 5th LNP Formulation & Process Development Summitglobenewswire.comApr 7